Package | Dosage | Price | Price per Dose | |
---|---|---|---|---|
Dosage: 1,5mg | ||||
360 pill | 1,5mg | €267.38 | €0.74 | |
240 pill | 1,5mg | €181.99 | €0.76 | |
180 pill | 1,5mg | €139.72 | €0.78 | |
120 pill | 1,5mg | €98.32 | €0.82 | |
90 pill | 1,5mg | €76.76 | €0.85 | |
60 pill | 1,5mg | €51.74 | €0.86 | |
30 pill | 1,5mg | €27.59 | €0.91 | |
Dosage: 3mg | ||||
360 pill | 3mg | €244.96 | €0.68 | |
240 pill | 3mg | €171.64 | €0.72 | |
180 pill | 3mg | €133.69 | €0.74 | |
120 pill | 3mg | €96.60 | €0.80 | |
90 pill | 3mg | €76.76 | €0.85 | |
60 pill | 3mg | €56.06 | €0.93 | |
30 pill | 3mg | €31.91 | €1.06 |

Rivastigmine Tartrate Description
Overview of Rivastigmine Tartrate
Rivastigmine Tartrate is a medication primarily used to treat symptoms related to Alzheimer's disease and Parkinson’s disease dementia. It belongs to a class of drugs known as cholinesterase inhibitors. These medications work by increasing the levels of a neurotransmitter called acetylcholine in the brain, which is often deficient in patients suffering from cognitive decline. By improving cholinergic communication, Rivastigmine helps in managing memory loss, confusion, and other cognitive difficulties associated with these neurodegenerative conditions.
Effectiveness and Benefits
Many patients and healthcare providers consider Rivastigmine Tartrate effective in slowing the progression of cognitive symptoms. It can improve memory, attention, and daily functioning in some individuals. While it is not a cure for Alzheimer's or Parkinson’s-related dementia, it can significantly enhance the quality of life by helping patients retain independence longer. The medication's benefits are typically observed within a few weeks of consistent use, though the degree of improvement varies among individuals.
Administration and Dosage
Rivastigmine Tartrate is available in various forms, including capsules, transdermal patches, and liquid solutions. The dosage depends on the patient's condition and response to treatment. It is usually started at a low dose to minimize side effects and then gradually increased as tolerated. The transdermal patch offers a convenient alternative to oral administration and can provide a steady release of medication, reducing gastrointestinal side effects often seen with oral forms.
Possible Side Effects
Though generally well-tolerated, Rivastigmine Tartrate can cause side effects in some users. Common adverse reactions include nausea, vomiting, diarrhea, dizziness, and loss of appetite. Some patients may experience muscle weakness or fatigue. Serious side effects are rare but may include heart rhythm disturbances or severe allergic reactions. Because of these potential effects, regular monitoring by a healthcare professional is recommended during treatment.
Considerations and Precautions
Before starting Rivastigmine, patients should inform their healthcare provider about any existing health issues, especially heart problems, liver or kidney conditions, or allergies. It is important to discuss all current medications, as Rivastigmine may interact with other drugs, including antihistamines and certain antidepressants. Pregnant or breastfeeding women should consult their doctor before using this medication. Additionally, caution is advised when performing activities that require full alertness until the effects of the medication are clear.
Conclusion
Rivastigmine Tartrate remains a valuable option in managing the symptoms of dementia associated with Alzheimer’s and Parkinson’s diseases. Its ability to enhance neurotransmitter function offers meaningful improvements for some patients. However, individual responses vary, and it is essential to approach its use under medical supervision. When used appropriately, Rivastigmine can contribute to a better quality of life by helping maintain cognitive functions for as long as possible.